Form 4 Tracker
NEUROCRINE BIOSCIENCES INC
NBIX

71 insider filings · Latest: Sep 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 8 10:07 PMLeslie V NorwalkDirector
Sale
1,250$168.06$210.1K2,838(D)

View →

Jun 5, 2026Jun 5 8:31 PMSTEPHEN SHERWIN
Proposed Sale
25,000$167.35$4.2M—

View →

Jun 2, 2026Jun 4 10:02 PMJulie CookeChief Human Resources Officer
Sale
36,937$156.22$5.8M22,374(D)

View →

Jun 1, 2026Jun 2 10:08 PMJude OnyiaChief Scientific Officer
Sale
11,000$160.25$1.8M25,846(D)

View →

May 29, 2026Jun 2 10:03 PMIngrid DelaetChief Regulatory Officer
Sale
2,261$156.71$354.3K16,225(D)

View →

Jun 2, 2026Jun 2 8:39 PMJULIE COOKE
Proposed Sale
36,937$161.00$5.9M—

View →

Jun 1, 2026Jun 1 8:25 PMJUDE ONYIA
Proposed Sale
11,000$158.30$1.7M—

View →

May 27, 2026May 29 10:09 PMJude OnyiaChief Scientific Officer
Sale
11,000$155.53$1.7M25,846(D)

View →

May 29, 2026May 29 8:25 PMINGRID DELAET
Proposed Sale
2,261$156.39$353.6K—

View →

May 26, 2026May 28 10:08 PMDavid W. BoyerChief Corp. Affairs Officer
Sale
3,888$156.64$609.0K7,799(D)

View →

May 27, 2026May 27 8:33 PMJUDE ONYIA
Proposed Sale
11,000$155.73$1.7M—

View →

May 26, 2026May 26 8:45 PMDAVID WARREN BOYER
Proposed Sale
3,888$156.70$609.2K—

View →

May 19, 2026May 21 9:49 PMKevin Charles GormanDirector
Sale
245,088$154.33$37.8M511,293(D)

View →

May 19, 2026May 19 8:31 PMKEVIN CHARLES GORMAN
Proposed Sale
245,088$157.21$38.5M—

View →

May 15, 2026May 18 9:50 PMPOPS RICHARD FDirector
Sale
15,000$157.65$2.4M34,480(D)

View →

May 15, 2026May 15 8:33 PMRICHARD F POPS
Proposed Sale
15,000$159.05$2.4M—

View →

May 12, 2026May 14 8:45 PMLeslie V NorwalkDirector
Sale
3,810$155.01$590.6K2,429(D)

View →

May 12, 2026May 12 6:35 PMNorwalk Leslie V
Proposed Sale
6,310$162.92$1.0M—

View →

Jan 16, 2026Jan 20 11:56 PMKyle GanoDirector, Chief Executive Officer
Sale
36,400$132.70$4.8M140,407(D)

View →

Jan 16, 2026Jan 16 9:21 PMKYLE GANO
Proposed Sale
36,400$133.35$4.9M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 27, 2026May 29 10:03 PMShalini SharpDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:03 PMSHERWIN STEPHEN ADirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:02 PMMORROW GEORGE JDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:02 PMWilliam H RastetterDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:01 PMLeslie V NorwalkDirector
Grant/Award
3,908$155.832,624(D)

View →

May 21, 2026May 21 11:24 PMSHERWIN STEPHEN ADirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:24 PMShalini SharpDirector
Option Exercise
1,659—0(D)

View →

May 21, 2026May 21 11:24 PMWilliam H RastetterDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:23 PMPOPS RICHARD FDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:22 PMChristine A PoonDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:22 PMLeslie V NorwalkDirector
Option Exercise
1,659—0(D)

View →

May 21, 2026May 21 11:21 PMMORROW GEORGE JDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:21 PMJohanna MercierDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:21 PMLYONS GARY ADirector
Option Exercise
1,659—0(D)

View →

May 19, 2026May 21 9:49 PMKevin Charles GormanDirector
Option Exercise
205,088$43.240(D)

View →

May 15, 2026May 18 9:50 PMPOPS RICHARD FDirector
Option Exercise
15,000$47.890(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
4,807—2,566(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Grant/Award
51,830$124.127,735(D)

View →

Feb 12, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
2,133—6,401(D)

View →

Feb 13, 2026Feb 17 10:48 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
3,352—1,812(D)

View →